CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Operating Expenses [Abstract]
Research and development	$ 14,240	$ 3,216	$ 24,947	$ 8,746
General and administrative	3,401	1,976	6,587	3,074
Total operating expenses	17,641	5,192	31,534	11,820
Operating loss	(17,641)	(5,192)	(31,534)	(11,820)
Other income (expense)
Interest income	250		259
Other income (expense), net	76	(197)	134	(205)
Total other income (expense), net	326	(197)	393	(205)
Net loss before income tax	(17,315)	(5,389)	(31,141)	(12,025)
Income tax expense			(4,420)
Net loss	$ (17,315)	$ (5,389)	$ (35,561)	$ (12,025)
Net loss per share, basic	$ (1.23)	$ (6.03)	$ (4.70)	$ (13.45)
Net loss per share, diluted	$ (1.23)	$ (6.03)	$ (4.70)	$ (13.45)
Weighted-average common shares outstanding, basic	14,090,455	894,060	7,563,283	894,060
Weighted-average common shares outstanding, diluted	14,090,455	894,060	7,563,283	894,060